Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Induction Healthcare Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 12.50.
Current Consensus is
N/A
The current consensus among 0 investment analysts is to n/a stock in Induction Healthcare Group. This N/A consensus rating has held steady for over two years.
Induction Healthcare Group PLC provides software to healthcare professionals in the United Kingdom, Europe, the United States, and internationally. It offers Induction Switch, hospital staff directory app that enables users to source, communicate, and share information with other healthcare professionals, as well as allows them to bypass legacy hospital switchboards; Induction Zesty, a digital patient engagement platform that ensures automated process for patients to manage their hospital appointments, view their letters and clinical records, as well as provides data remotely via digital questionnaires; Induction Guidance, a platform to create, edit, and publish their own local medical guidance and policies; and Induction Attend Anywhere, which offers video consultations to patients and service users to help hospitals, health systems, and other customers. Induction Healthcare Group PLC was incorporated in 2019 and is based in London, the United Kingdom.
Read More
